✦ LIBER ✦

CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial

✍ Scribed by E. Montserrat; J. García-Conde; N. Viñolas; A. López-Guillermo; L. Hernández-Nieto; A. Zubizarreta; J. Maldonado; A. Alcalá; M.-V. Faura; A. Llorente; J. Bladé; M. Fontanillas; J. Estapé; (PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment; Spanish Society of Hematology)

Book ID: 114792172
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 533 KB
Volume: 57
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1996.tb01396.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHOP vs MEV for the treatment of non-Hod

CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: A randomized clinical trial

✍ Hagberg, H.; Björkholm, M.; Glimelius, B.; Lindemalm, Ch.; Mellstedt, H.; Killan 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 516 KB

Comparison of CHOP-B vs CEOP-B in ‘poor

Comparison of CHOP-B vs CEOP-B in ‘poor prognosis’ non-Hodgkin’s lymphomas. A randomized trial

✍ De Lena, Mario ;Maiello, Evaristo ;Lorusso, Vito ;Brandi, Mario ;Calabrese, Pier 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 501 KB

A phase III comparison of CHOP vs. m-BAC

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

✍ Fisher, R. I.; Gaynor, E. R.; Dahlberg, S.; Oken, M. M.; Grogan, T. M.; Mize, E. 📂 Article 📅 1994 🏛 Oxford University Press 🌐 English ⚖ 522 KB

Long-term Results of a Multicenter Rando

Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin’s Lymphoma

✍ Mayumi Mori; Kiyoshi Kitamura; Michihiko Masuda; Tomomitsu Hotta; Tamotsu Miyaza 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 161 KB

WITHDRAWN: Addition of amifostine to CHO

WITHDRAWN: Addition of amifostine to CHOP regimen significantly reduced toxicity in patients with aggressive non-Hodgkin’s lymphoma without affecting the long term survival: Results of a phase II trial

✍ Gómez, Henry L. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 29 KB

Treatment of low-grade non-Hodgkin's lym

Treatment of low-grade non-Hodgkin's lymphomas (NHL) with CVP ± interferon alfa-2B (IFN). A multicenter randomized prospective trial preliminary results

✍ Arranz, R.; Lavilla, E.; García Alfonao, P.; Carrión, R.; Zamora, P.; Esphosa, E 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 179 KB